100382-00-1 Usage
Uses
Used in Pharmaceutical Industry:
4-Benzyloxy-2-cyanopyridine is used as an intermediate in organic synthesis for the production of various pharmaceuticals. Its versatile structure allows for the synthesis of diverse functionalized pyridine derivatives, which are essential in the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical industry, 4-Benzyloxy-2-cyanopyridine is used as a building block for the synthesis of various agrochemicals. Its potential applications in this field include the development of new pesticides and other agricultural chemicals.
Used in Medicinal Chemistry Research:
4-Benzyloxy-2-cyanopyridine is used as a significant molecule in medicinal chemistry research due to its potential antiproliferative and antitumor activities. Researchers are exploring its potential as a therapeutic agent for various diseases, including cancer.
Used in Fine Chemicals Industry:
In the fine chemicals industry, 4-Benzyloxy-2-cyanopyridine is used as an intermediate for the synthesis of various specialty chemicals. Its unique structure and functional groups make it a valuable component in the production of high-value chemicals for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 100382-00-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,3,8 and 2 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 100382-00:
(8*1)+(7*0)+(6*0)+(5*3)+(4*8)+(3*2)+(2*0)+(1*0)=61
61 % 10 = 1
So 100382-00-1 is a valid CAS Registry Number.
100382-00-1Relevant articles and documents
COMPOUNDS AND USES THEREOF
-
Page/Page column 161, (2021/08/06)
The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME
-
Paragraph 00182, (2018/03/06)
Disclosed herein, in part, are fumagillol compounds and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
The first total synthesis of novel human chymase inhibitor SPF32629A
Vegi, Srinivasa Rao,Boovanahalli, Shanthaveerappa K.,Sharma, Arun Prakash,Mukkanti
scheme or table, p. 6297 - 6299 (2009/04/07)
The first total synthesis of SPF32629A, a novel human chymase inhibitor, has been accomplished from the readily available precursor 4-nitropyridine N-oxide, following an efficient strategy with a sequence of eight straightforward steps.
